The “ColoSense” multitarget stool RNA test has demonstrated superior sensitivity and specificity for detecting colorectal cancer and advanced adenomas compared…
Trending
- Why physician is not the same as provider (KevinMD)
- The buyer map has changed — and physician practices are running out of exits (Becker’s Healthcare)
- The $5 Million Doctor: Inside the Quiet Surge in Physician Wealth (Medscape)
- UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening (Guardant Health)
- A disciplined approach to large-polyp EMR (GI & Hepatology News)
- Planet First Partners Invests in Iterative Health (Planet First Partners)
- What does SpaceX have to do with GI?
- Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer (Business Wire)
